Executive Summary
Global Assisted Reproductive Technology Market was valued at USD 24133.23 Million in the year 2019. Delay in age of first time pregnancy has led to lowering of total fertility rate (TFR) globally. Growing stress levels, escalation in pollution levels, modern lifestyle with increase in alcohol consumption and smoking are all cumulatively leading to increase in male and female infertility. Acceptance of homosexual couples and single mothers surging in number for use of ART are anticipated to lead market growth in the forecast period of 2020-2025.
Various techniques such as In Vitro fertilization (IVF), Artificial Insemination, Zygote Intra-fallopian transfer (ZIFT), Gamete Intra-fallopian Transfer (GIFT) are used according to need of the patient. In Vitro fertilization is considered as Gold standard for ART due to high success rate for embryo transfer and increase in live birth rates. Drugs such as orals and hormones which are injectable, are used prior to ART treatment and also during the treatment to prepare the body. Drugs market is estimated to grow heavily with elaborate pipeline. Moreover, INVOcell and Anecova have developed In vivo ART devices, which are likely to facilitate market growth in the forecast period.
Among the regions, Asia Pacific, followed by Europe and Americas, will experience the highest growth rate owing to decrease in male and female fertility.
Scope of the Report
- The report analyses Assisted Reproductive Technology Market at global, regional and country-levels.
- The report analyses Assisted Reproductive Technology Market By Technology (In vitro Fertilization, Artificial Insemination, Others).
- The report assesses the Assisted Reproductive Technology Market By End User (Hospitals, Fertility clinics).
- The report assesses the Assisted Reproductive Technology Market By Products (Consumables, Instruments, Software and Services, Drugs).
- The Global Assisted Reproductive Technology Market has been analysed By Region (Americas, Europe, Asia Pacific) and By Country (USA, Canada, Brazil, Mexico, China, Japan, India, UK, Germany, Italy).
- The key insights of the report have been presented through the frameworks of Key developments and drug pipeline phases. Also, the attractiveness of the market has been presented by Technology, End User, Products and Region. Additionally, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
- The companies analysed in the report include Merck, Hamilton Thorne, Cooper Surgical, Nidacon International AB, Anecova, Esco, INVO Bioscience, Monash IVF Group, Irvine Scientific.
- The report presents the analysis of Assisted Reproductive Technology market for the historical period of 2015-2019 and the forecast period of 2020-2025.
Key Target Audience
- Pharmaceutical Firms
- IVF Clinics and Hospitals
- Consulting and Advisory Firms
- Medical Practitioners